To confirm the immune-inhibitory potential of HLA-G, we constructed HLA-G-overexpressing K562 cells; this human erythroleukemia cell line lacks HLA-I expression and is thus highly vulnerable to NK cells. This evidence concerns the gene HLA-G and erythroleukemia.